Exelixis, Inc. (NASDAQ:EXEL) registered a -0.69% decrease, still its new closing price is 426.48% up from the company’s 1 year high of 19.30.It posted 1.03% gains in previous 5 sessions and is now the subject of 0 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 4 buy or better ratings. The 6 stock analysts following this company have an average price target at $19.50, with individual PT in the $17.00-$21.00 range. The shares moved at $18.69, implying that brokerage firms see shares gaining about 321.90% in twelve months time.

Exelixis, Inc. (EXEL) SEC Form 4 News

The stock is getting much attention these days as insiders are offloading shares while they posted a 25.35% rise year to date. A EVP, Scientific Strategy & CSO at Exelixis, Inc. (EXEL) offloaded shares in a transaction closed on Tuesday January 03, 2017. Lamb Peter sold 70,000 shares in the company at $14.65 each and collected $1,025,001 in proceeds. Lamb Peter now owns 89,624 shares in the company after this transaction. A Director in the company, FELDBAUM CARL B, disclosed a transaction on Friday December 16, 2016 that ended up generating $425,001 from the sale of 25,000 shares at $17.03 per share.

Exelixis, Inc. (NASDAQ:EXEL) Upcoming Results on Tap

Exelixis, Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $-0.00 in that period. Sales during the quarter are predicted to arrive at $68.87 million.

Earnings surprise history: Last quarter, the company posted approximately $62.19 million in revenue and EPS of $-0.04. The mean forecast was for $45.48 million and $-0.12 a share, respectively. One quarter earlier, revenue for the stock was at $36.25 million, with earnings at $-0.16/share.

Exelixis, Inc. (EXEL) Brokerage Update

Exelixis, Inc. (EXEL) is in Piper Jaffray’s research list so their analyst rating change is noteworthy. These shares were upgraded to Overweight from Neutral by Piper Jaffray, according to news reported on Monday October 10, 2016.Another important research note was issued by Stifel on Monday April 04, 2016.The firm upgraded EXEL to Buy from Hold. Over the last six months and over the last three months, the shares of Exelixis, Inc. (EXEL), have changed 99.04% and 70.22%, respectively.